Transfection reagents: matching the chemistry to the cell type and the cargo, and optimising without burning through kits

Transfection efficiency is a property of the cell type at least as much as of the reagent, and the reagent that a colleague swears by may do nothing in your line. That is why every supplier offers a selection guide and why optimisation, done systematically once, is worth far more than switching products repeatedly. This page covers choosing a starting point and optimising efficiently.

the FDA labelling clause behind research use only on a reagent
809.10(c)
good laboratory practice for nonclinical studies, 21 CFR
Part 58
hazard communication, which decides what the container must tell the user
1910.1200

Figures in this panel are the rules that decide what a reagent may claim and what its container must say, named from the regulations themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.

Choosing and optimising

  1. Cell type comes first. Easy adherent lines transfect with almost anything; primary cells, suspension cells and hard lines frequently need a specific chemistry or a physical method. Start from published or supplier data for your exact cell type rather than from a general recommendation.
  2. The cargo changes the chemistry. Plasmid DNA, small interfering RNA, messenger RNA and ribonucleoprotein complexes have different sizes and charges and are not delivered equally well by one reagent. Suppliers sell different products for these because the difference is real.
  3. Optimise ratio and amount together. Reagent to nucleic acid ratio, total nucleic acid per well and cell confluence at transfection interact, so vary them as a small grid once rather than one at a time repeatedly. A single properly designed optimisation plate saves weeks.
  4. Watch cytotoxicity, not only efficiency. High efficiency with substantial cell death gives a population selected by survival, which distorts whatever you measure next. Track viability alongside efficiency and choose a condition that balances both.
  5. Serum, antibiotics and medium. Some reagents are inhibited by serum and some require its absence during complex formation, and antibiotics in the medium raise toxicity in permeabilised cells. Follow the reagent's protocol on these points before concluding that it does not work.

Chemical against physical delivery

Lipid and polymer reagents are cheap, simple and effective in many lines. Electroporation and nucleofection reach primary and suspension cells that chemical methods do not, at the cost of an instrument, consumables and some cell death.

Viral delivery is a different category again, appropriate where stable expression or genuinely hard targets are required, with the additional containment and approvals that come with it.

Controls that make the result interpretable

A fluorescent reporter control tells you the efficiency achieved, a non-targeting control separates the effect of the cargo from the effect of the procedure, and an untransfected control shows what the cells do untouched. All three are cheap and all three are routinely omitted.

Record the passage number and confluence, because transfection efficiency drifts with both and an unexplained change between experiments is frequently one of them.

Common questions

Which transfection reagent should I use?
Start from data for your exact cell type and cargo rather than a general recommendation, because efficiency depends on the cell line at least as much as on the reagent. Suppliers publish cell type guides for this reason.
Why is my transfection efficiency low?
Common causes are the wrong chemistry for the cell type, poor nucleic acid quality, confluence outside the optimal window, serum or antibiotic interference, and an unoptimised reagent to nucleic acid ratio.
Chemical reagent or electroporation?
Chemical reagents are cheap and effective for many adherent lines. Electroporation and nucleofection reach primary and suspension cells that chemical methods cannot, at the cost of an instrument and some cell death.
What controls should I include?
A fluorescent reporter to measure efficiency, a non-targeting cargo to separate the cargo's effect from the procedure's, and untransfected cells. Record passage number and confluence alongside.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/transfection-reagents/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices